tiprankstipranks
Kazia Therapeutics Limited (KZIA)
NASDAQ:KZIA
US Market
KZIA
Kazia Therapeutics
RESEARCH TOOLSreports

Kazia Therapeutics (KZIA) Income Statement

328 Followers

Kazia Therapeutics Income Statement

Last quarter (Q2 2026), Kazia Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q2, Kazia Therapeutics's net income was AU$-12.32M. See Kazia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 42.00KAU$ 2.31MAU$ 555.00AU$ 10.00KAU$ 15.18M
Gross Profit
AU$ 42.00KAU$ 2.31MAU$ 555.00AU$ 10.00KAU$ 15.18M
Operating Expenses
AU$ 14.26MAU$ 30.77MAU$ 24.12MAU$ 25.41MAU$ 21.56M
Depreciation and Amortization
AU$ 934.00KAU$ 1.87MAU$ 1.87MAU$ 1.87MAU$ 1.26M
EBITDA
AU$ -13.28MAU$ -26.59MAU$ -22.28MAU$ -23.52MAU$ -5.11M
Operating Income
AU$ -14.22MAU$ -28.46MAU$ -24.12MAU$ -25.40MAU$ -6.38M
Other Income/Expenses
AU$ -8.23MAU$ 1.41MAU$ 3.41MAU$ 17.00KAU$ -2.53M
Pretax Income
AU$ -22.45MAU$ -27.05MAU$ -20.74MAU$ -25.38MAU$ -8.90M
Net Income
AU$ -20.70MAU$ -26.78MAU$ -20.47MAU$ -25.01MAU$ -8.42M
Per Share Metrics
Basic EPS
AU$ -18.90AU$ -55.00AU$ -55.00AU$ -95.00AU$ -35.80
Diluted EPS
AU$ -18.90AU$ -55.00AU$ -55.00AU$ -95.00AU$ -35.80
Weighted Average Shares Outstanding
 1.10M 479.60K 368.60K 265.00K 235.40K
Weighted Average Shares Outstanding (Diluted)
 1.10M 479.60K 368.60K 265.00K 235.40K
Currency in AUD

Kazia Therapeutics Earnings and Revenue History